tiprankstipranks
Silo Pharma (SILO)
NASDAQ:SILO
US Market
SILO
Silo Pharma
RESEARCH TOOLSreports
Want to see SILO full AI Analyst Report?

Silo Pharma (SILO) Income Statement

222 Followers

Silo Pharma Income Statement

Last quarter (Q4 2025), Silo Pharma's total revenue was $18.03K, a decrease of 0.00% from the same quarter last year. In Q4, Silo Pharma's net income was $-881.53K. See Silo Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 72.10K$ 72.10K$ 72.10K$ 72.10K$ 71.26K
Gross Profit
$ -813.96K$ 66.26K$ 66.26K$ 66.26K$ 66.26K
Operating Expenses
$ 3.47M$ 4.77M$ 3.92M$ 3.69M$ 2.81M
Depreciation and Amortization
$ 11.44K$ 6.18K$ 0.00$ 0.00$ 0.00
EBITDA
$ -4.28M$ -4.38M$ -3.63M$ -3.91M$ 4.19M
Operating Income
$ -4.28M$ -4.71M$ -3.86M$ -3.63M$ -2.74M
Other Income/Expenses
$ 52.96K$ 312.81K$ 224.51K$ -279.73K$ 6.93M
Pretax Income
$ -4.23M$ -4.39M$ -3.63M$ -3.91M$ 4.18M
Net Income
$ -4.23M$ -4.39M$ -3.70M$ -3.91M$ 3.90M
Per Share Metrics
Basic EPS
$ -0.50$ -1.19$ -1.20$ -1.71$ 1.32
Diluted EPS
$ -0.50$ -1.19$ -1.20$ -1.71$ 1.30
Weighted Average Shares Outstanding
 8.38M 3.68M 3.08M 2.28M 1.90M
Weighted Average Shares Outstanding (Diluted)
 8.38M 3.68M 3.08M 2.28M 1.92M
Currency in USD

Silo Pharma Earnings and Revenue History